We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adient (ADNT - Free Report) reported adjusted earnings per share (EPS) of 69 cents for the second quarter of fiscal 2025. Earnings rose from 54 cents recorded in the year-ago period and surpassed the Zacks Consensus Estimate of 36 cents.
The company generated net sales of $3.61 billion, which decreased 4% year over year but beat the Zacks Consensus Estimate of $3.47 billion.
Adient currently operates through three reportable segments — Americas, including North America and South America; Europe, which includes the Middle East and Africa (EMEA); and Asia Pacific/China (Asia).
In the reported quarter, the Americas segment recorded revenues of $1.70 billion, which rose 2.3% from the year-ago period and topped the Zacks Consensus Estimate of $1.59 billion. The segment recorded an adjusted EBITDA of $94 million, which increased from $80 million recorded in the prior-year quarter due to favorable volume and mix, improved business performance and favorable impact of forex movements. The metric also surpassed the Zacks Consensus Estimate of $79 million.
The EMEA segment registered revenues of $1.23 billion, which declined 10.1% year over year but topped the Zacks Consensus Estimate of $1.16 billion. The segment recorded an adjusted EBITDA of $50 million, which declined from $57 million generated in the year-ago period due to headwinds from volume/mix and the unfavorable impact of forex movement. The metric, however, surpassed the Zacks Consensus Estimate of $33.39 million
In the fiscal second quarter, revenues in the Asia segment came in at $707 million, which fell from $742 million in the second quarter of fiscal 2024 and missed the Zacks Consensus Estimate of $736 million. The segment recorded an adjusted EBITDA of $110 million, slightly down from $112 million recorded in the corresponding quarter of fiscal 2024 due to unfavorable volume and mix in China. The figure also missed the Zacks Consensus Estimate of $114 million.
(Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Adient’s Financial Position
Adient had cash and cash equivalents of $754 million as of March 31, 2025, compared with $945 million as of Sept. 30, 2024.
As of March 31, 2025, long-term debt amounted to $2.39 billion.
Capital expenditures totaled $109 million compared with $124 million in the prior-year quarter.
ADNT Updates Guidance for FY25
Adient envisions fiscal 2025 revenues to be $13.9 billion, the same as the previous estimate. Adjusted EBITDA is estimated to be $850 million, the same as the previous estimate. Equity income is projected to be $80 million.
Free cash flow is now anticipated to be in the range of $150-$170 million, down from the previous estimate of $180 million. Capex is estimated to be $285 million. Cash tax is expected to be $105 million. Interest expenses are projected to be $190 million, up from the previous estimate of $185 million.
The Zacks Consensus Estimate for HSAI’s 2025 earnings indicates year-over-year growth of 336.36%, respectively. EPS estimates for 2026 have improved 12 cents in the past 30 days.
The Zacks Consensus Estimate for SMP’s 2025 sales and earnings implies year-over-year growth of 17.1% and 12.62%, respectively. EPS estimates for 2025 and 2026 have improved 6 cents and a penny, respectively, in the past seven days.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Adient Q2 Earnings Surpass Expectations, FCF View Lowered
Adient (ADNT - Free Report) reported adjusted earnings per share (EPS) of 69 cents for the second quarter of fiscal 2025. Earnings rose from 54 cents recorded in the year-ago period and surpassed the Zacks Consensus Estimate of 36 cents.
The company generated net sales of $3.61 billion, which decreased 4% year over year but beat the Zacks Consensus Estimate of $3.47 billion.
Adient Price, Consensus and EPS Surprise
Adient price-consensus-eps-surprise-chart | Adient Quote
Segmental Performance of ADNT
Adient currently operates through three reportable segments — Americas, including North America and South America; Europe, which includes the Middle East and Africa (EMEA); and Asia Pacific/China (Asia).
In the reported quarter, the Americas segment recorded revenues of $1.70 billion, which rose 2.3% from the year-ago period and topped the Zacks Consensus Estimate of $1.59 billion. The segment recorded an adjusted EBITDA of $94 million, which increased from $80 million recorded in the prior-year quarter due to favorable volume and mix, improved business performance and favorable impact of forex movements. The metric also surpassed the Zacks Consensus Estimate of $79 million.
The EMEA segment registered revenues of $1.23 billion, which declined 10.1% year over year but topped the Zacks Consensus Estimate of $1.16 billion. The segment recorded an adjusted EBITDA of $50 million, which declined from $57 million generated in the year-ago period due to headwinds from volume/mix and the unfavorable impact of forex movement. The metric, however, surpassed the Zacks Consensus Estimate of $33.39 million
In the fiscal second quarter, revenues in the Asia segment came in at $707 million, which fell from $742 million in the second quarter of fiscal 2024 and missed the Zacks Consensus Estimate of $736 million. The segment recorded an adjusted EBITDA of $110 million, slightly down from $112 million recorded in the corresponding quarter of fiscal 2024 due to unfavorable volume and mix in China. The figure also missed the Zacks Consensus Estimate of $114 million.
(Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)
Adient’s Financial Position
Adient had cash and cash equivalents of $754 million as of March 31, 2025, compared with $945 million as of Sept. 30, 2024.
As of March 31, 2025, long-term debt amounted to $2.39 billion.
Capital expenditures totaled $109 million compared with $124 million in the prior-year quarter.
ADNT Updates Guidance for FY25
Adient envisions fiscal 2025 revenues to be $13.9 billion, the same as the previous estimate. Adjusted EBITDA is estimated to be $850 million, the same as the previous estimate. Equity income is projected to be $80 million.
Free cash flow is now anticipated to be in the range of $150-$170 million, down from the previous estimate of $180 million. Capex is estimated to be $285 million. Cash tax is expected to be $105 million. Interest expenses are projected to be $190 million, up from the previous estimate of $185 million.
Adient’s Zacks Rank & Key Picks
ADNT carries a Zacks Rank #3 (Hold) at present.
Some better-ranked stocks in the auto space are Hesai Group (HSAI - Free Report) and Standard Motor Products, Inc. (SMP - Free Report) . HSAI sports a Zacks Rank #1 (Strong Buy), while SMP carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for HSAI’s 2025 earnings indicates year-over-year growth of 336.36%, respectively. EPS estimates for 2026 have improved 12 cents in the past 30 days.
The Zacks Consensus Estimate for SMP’s 2025 sales and earnings implies year-over-year growth of 17.1% and 12.62%, respectively. EPS estimates for 2025 and 2026 have improved 6 cents and a penny, respectively, in the past seven days.